Scientists at the UCLA Health Jonsson Comprehensive Cancer Center have developed a new cytokine-armored CAR-T cell therapy ...
New approach recruits the body’s immune system to attack glioblastoma while reducing treatment-related toxicity.
Renier Brentjens, MD, PhD, one of the pioneers in the development of chimeric antigen receptor (CAR) T-cell therapy, is poised to see the technology take its next big leap, with researchers testing ...
BUFFALO, N.Y. — There is new research happening at Roswell Park Comprehensive Cancer Center to see if CAR T-cell therapy that has worked for cancer patients can be used to help patients with ...
CAR-T cell therapy is already a potent treatment for certain cancers. Now, a small study is showing early promise for ...
In a phase 1 study, anti-CD7 chimeric antigen receptor (CAR) T cells induced complete remission in children and adults with relapsed or refractory T-cell acute lymphoblastic leukemia (ALL), with 82% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results